Thomas Ebeling

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Thomas Ebeling

Earlier roles on record: Board Member at Cullinan Therapeutics, Inc. (CGEM) until June 26, 2024. Cullinan Therapeutics, Inc. reported in an 8-K filed May 15, 2024 that Thomas Ebeling resigned as director, effective June 26, 2024.

“Additionally, on May 9, 2024, Thomas Ebeling notified the Board of his intention to serve out his current term and resign as a director effective as of June 26, 2024.”

Cullinan Therapeutics, Inc. Form 8-K, filed May 15, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Thomas Ebeling's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Cullinan Therapeutics, Inc. (CGEM)
Board Member

Proxy statement

2017-01-01–2024-06-26
Cullinan Therapeutics, Inc. (CGEM)
Board Member

Proxy statement

2017-01-01–2024-06-26

Company network

Recorded roles and call appearances connecting this person to public companies.

Cullinan Therapeutics, Inc.

CGEM

Board Member

2017-01-01–2024-06-26

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: director Cullinan Therapeutics, Inc. (CGEM)
2024-06-26